GLOW: The BPC-157 + TB-500 Recovery Stack

Two peptides, two mechanisms

GLOW is a pre-blended research vial pairing BPC-157 with TB-500. The two show up together so often in recovery research because they act through different, complementary mechanisms.

BPC-157

A gastric pentadecapeptide studied in tissue-repair models for local healing and angiogenesis.

TB-500

TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid actin-binding protein; the fragment corresponds to the protein's active region. In preclinical research, Tβ4 and TB-500 are studied for:

• Actin regulation and cell migration, how cells move toward a site of injury
• Angiogenesis and tissue remodeling
• A more systemic distribution, versus BPC-157's more localized profile

Why blend them

The research rationale for the pairing is complementary coverage: BPC-157's local repair and angiogenesis signal alongside TB-500's actin-driven cell migration and systemic reach, combined in one vial so there's nothing to reconstitute twice.

Research status

Both are preclinical research compounds, not approved drugs. For laboratory research use only. Not for human consumption.